Advertisement

Topics

Priority review for Gilead's triple combination HIV candidate

07:34 EDT 11 Aug 2017 | thePharmaLetter

Californian biotech firm Gilead Sciences has received priority review status from the US FDA for an investigational…

Original Article: Priority review for Gilead's triple combination HIV candidate

NEXT ARTICLE

More From BioPortfolio on "Priority review for Gilead's triple combination HIV candidate"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...